000 01574 a2200385 4500
005 20250515181211.0
264 0 _c20090915
008 200909s 0 0 eng d
022 _a1473-5709
024 7 _a10.1097/CEJ.0b013e32832e0955
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGatenby, Piers A
245 0 0 _aAspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
_h[electronic resource]
260 _bEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
_cSep 2009
300 _a381-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xepidemiology
650 0 4 _aAnticarcinogenic Agents
_xtherapeutic use
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aBarrett Esophagus
_xdrug therapy
650 0 4 _aCohort Studies
650 0 4 _aDemography
650 0 4 _aEsophageal Neoplasms
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrecancerous Conditions
_xdrug therapy
700 1 _aRamus, James R
700 1 _aCaygill, Christine P
700 1 _aWinslet, Marc C
700 1 _aWatson, Anthony
773 0 _tEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
_gvol. 18
_gno. 5
_gp. 381-4
856 4 0 _uhttps://doi.org/10.1097/CEJ.0b013e32832e0955
_zAvailable from publisher's website
999 _c19029805
_d19029805